ARCHIVES

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants

October 28, 1988

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

NIH funds four centers to study breast cancer and the environment.

October 17, 2003

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

In Brief: Coalition Begins Campaign To Educate Public

February 3, 1995

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013